EP Patent

EP1512395A1 — Biodegradable macromers for the controlled release of biologically active substances

Assigned to Azopax Therapeutics LLC · Expires 2005-03-09 · 21y expired

What this patent protects

A method for delivering a biologically active substance including the steps of: (a) combining said biologically active substance with a macromer; (b) forming a mixture of the combination formed in step (a); (c) polymerizing said mixture to form articles; and (d) administering sai…

USPTO Abstract

A method for delivering a biologically active substance including the steps of: (a) combining said biologically active substance with a macromer; (b) forming a mixture of the combination formed in step (a); (c) polymerizing said mixture to form articles; and (d) administering said articles, or a portion thereof, to a mammal, where step (c) takes place in the absence of a polymerizable monovinyl monomer, is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP1512395A1
Jurisdiction
EP
Classification
—
Expires
2005-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Azopax Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.